InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding InMed Pharmaceuticals Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 10 | 10 | 0 |
| Shares | 15.8K | 26.9K | +11.1K (+70.7%) |
| Value | $14.5K | $18.6K | +$4.04K (+27.8%) |
New holders (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 69 | $48 | 0.00% |
| Gables Capital Management Inc. | 1 | $1 | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of America Corp | 1,834 | $1.70K |
| BlackRock Inc. | 50 | $46 |